SANUWAVE Health

About:

SANUWAVE Health develops a shock wave technology used in devices for the repair and regeneration of bones, muscles, tendons, and skin.

Website: http://www.sanuwave.com

Top Investors: Manchester Management, RA Capital Management, Opaleye Management, AWM Investment Company

Description:

SANUWAVE Health is a developer of a high-energy, focused, shock wave technology that is used in devices for the repair and regeneration of bones, muscles, tendons, and skin, and for the separation of solids and fluid in non-medical systems. Within healthcare, SANUWAVE’s proprietary, patented Pulsed Acoustic Cellular Expression (PACE) technology emits high-energy, acoustic shock waves that restore the body’s normal healing processes. This activates biological signaling, which leads to tissue repair and regeneration, blood vessel growth, revascularization, and microcirculatory enhancement.

Total Funding Amount:

$58M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Alpharetta, Georgia, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)sanuwave.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2024-10-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai